1. Home
  2. Research
  3. Research Groups
  4. Cardiovascular diseases

Cardiovascular diseases

Search for publications

Only original articles, editorials, guidelines.

  • Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

    2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

    Revista espanola de cardiologia (English ed.) . 71(2): 110-110.

    [doi:10.1016/j.rec.2017.12.013]

  • Haugaa KH, Potpara TS, Boveda S, Deharo JC, Chen J, Dobreanu D, Fumagalli S, Lenarczyk R, Hernandez Madrid A, Larsen TB, Sciarrafia E, Taborsky M, Tilz RR, Pieragnoli P, Przybylski A, Dagres N.

    Patients' knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association.

    EUROPACE . 20(2): 386-391. Number of citations: 23

    [doi:10.1093/europace/eux365]

  • Jimenez D, Nieto R, Corres J, Fernández-Golfín C, Barrios D, Morillo R, Quezada CA, Huisman M, Yusen RD, Kline J.

    Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.

    THROMBOSIS RESEARCH . 162: 1-6. Number of citations: 3

    [doi:10.1016/j.thromres.2017.12.002]

  • De Caterina R, Brüggenjürgen B, Darius H, Köhler S, Lucerna M, Pecen L, Renda G, Schilling RJ, Schliephacke T, Zamorano JL, Le Heuzey JY, Kirchhof P.

    Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.

    ARCHIVES OF CARDIOVASCULAR DISEASES . 111(2): 74-84. Number of citations: 18

    [doi:10.1016/j.acvd.2017.04.007]

  • Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, ESC National Cardiac Societies.

    2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    EUROPEAN HEART JOURNAL . 39(3): 213-260. Number of citations: 1277

    [doi:10.1093/eurheartj/ehx419]

  • Cervigon, Raquel, Castells, Francisco, Manuel Gomez-Pulido, Jose, Perez-Villacastin, Julian, Moreno, Javier.

    Granger Causality and Jensen-Shannon Divergence to Determine Dominant Atrial Area in Atrial Fibrillation

    ENTROPY . 20(1): . Number of citations: 8

    [doi:10.3390/e20010057]

  • Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN.

    2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY . 53(1): 34-78. Number of citations: 119

    [doi:10.1093/ejcts/ezx334]

  • Baumgartner H, Falk V, Bax JJ, Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Munoz DR, Rosenhek R, Sjögren J, Mas PT, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL.

    2017 ESC/EACTS Guidelines for the management of valvular heart disease].

    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA . 76(1): 1-62. Number of citations: 43

    [doi:10.5603/KP.2018.0013]

  • Olivotto I, Camici PG, Merlini PA, Rapezzi C, Patten M, Climent V, Sinagra G, Tomberli B, Marin F, Ehlermann P, Maier LS, Fornaro A, Jacobshagen C, Ganau A, Moretti L, Hernandez Madrid A, Coppini R, Reggiardo G, Poggesi C, Fattirolli F, Belardinelli L, Gensini G, Mugelli A.

    Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study.

    CIRCULATION-HEART FAILURE . 11(1): 4124-4124. Number of citations: 50

    [doi:10.1161/CIRCHEARTFAILURE.117.004124]

  • Escobar C, Barrios V, Pérez de Isla L.

    Niveles óptimos de colesterol en los pacientes con dislipemia. Revisión sistemática de la evidencia.

    MEDICINA DE FAMILIA-SEMERGEN . 44(1): 42-49.

    [doi:10.1016/j.semerg.2017.08.006]

  • Medvedofsky D, Mor-Avi V, Amzulescu M, Fernández-Golfín C, Hinojar R, Monaghan MJ, Otani K, Reiken J, Takeuchi M, Tsang W, Vanoverschelde JL, Indrajith M, Weinert L, Zamorano JL, Lang RM.

    Three-dimensional echocardiographic quantification of the left-heart chambers using an automated adaptive analytics algorithm: multicentre validation study.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 19(1): 47-58. Number of citations: 51

    [doi:10.1093/ehjci/jew328]

  • José Bagur M, Alonso Salinas GL, Jiménez-Monreal AM, Chaouqi S, Llorens S, Martínez-Tomé M, Alonso GL.

    Saffron: An Old Medicinal Plant and a Potential Novel Functional Food.

    Molecules . 23(1): . Number of citations: 76

    [doi:10.3390/molecules23010030]

  • Hinojar R, Fernández-Golfín C, González-Gómez A, Rincón LM, Plaza-Martin M, Casas E, García-Martín A, Fernandez-Mendez MA, Esteban A, Nacher JJJ, Zamorano JL.

    Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 249: 467-472. Number of citations: 40

    [doi:10.1016/j.ijcard.2017.07.087]

  • González Gómez A, Fernández-Golfín C, Monteagudo JM, Izurieta C, Hinojar R, García A, Casas E, Jiménez-Nacher JJ, Moya JL, Ruiz S, Zamorano JL.

    Severe aortic stenosis patients with preserved ejection fraction according to flow and gradient classification: Prevalence and outcomes.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 248: 211-215. Number of citations: 6

    [doi:10.1016/j.ijcard.2017.06.064]

  • Grande E, Glen H, Aller J, Argenziano G, Lamas MJ, Ruszniewski P, Zamorano JL, Edmonds K, Sarker S, Staehler M, Larkin J.

    Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma.

    EXPERT OPINION ON DRUG SAFETY . 16(12): 1413-1426. Number of citations: 2

    [doi:10.1080/14740338.2017.1380624]

  • Antunes MJ, Rodríguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, Barili F, Casselman F, Folliguet T, Iung B, Lancellotti P, Muneretto C, Obadia JF, Pierard L, Suwalski P, Zamorano P, ESC Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

    Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease.

    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY . 52(6): 1022-1030. Number of citations: 86

    [doi:10.1093/ejcts/ezx279]

  • Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, Nihoyannopoulos P, Edvardsen T, Lancellotti P, EACVI Scientific Documents Committee for 2014–16 and 2016–18, EACVI Scientific Documents Committee for 2014–16 and 2016–18.

    Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 18(11): . Number of citations: 101

    [doi:10.1093/ehjci/jex182]

  • Salido Tahoces L, Hernández Antolín RA, Zamorano Gómez JL.

    Aortic stenosis. Indications and results of percutaneous aortic valve implantation (TAVI).

    REVISTA CLINICA ESPANOLA . 217(8): 478-483.

    [doi:10.1016/j.rce.2017.05.001]